Gregory Russotti - 07 Mar 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Title: Chief Technology and Manufacturing Officer; Exhibit 24 - Power of Attorney
Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
07 Mar 2024
Net transactions value
$0
Form type
4
Filing time
11 Mar 2024, 19:36:41 UTC
Previous filing
13 Apr 2023
Next filing
24 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Award $0 +24,000 +8.6% $0.000000 302,319 07 Mar 2024 Direct F1
holding IPSC Common Stock 92,773 07 Mar 2024 By Gregory Russotti 2021 Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +146,000 $0.000000 146,000 07 Mar 2024 Common Stock 146,000 $5.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
F2 The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Remarks:

Title: Chief Technology and Manufacturing Officer; Exhibit 24 - Power of Attorney